199 related articles for article (PubMed ID: 8626723)
1. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY
J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723
[TBL] [Abstract][Full Text] [Related]
2. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
van der Geer P; Wiley S; Pawson T
Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
[TBL] [Abstract][Full Text] [Related]
3. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.
Gustafson TA; He W; Craparo A; Schaub CD; O'Neill TJ
Mol Cell Biol; 1995 May; 15(5):2500-8. PubMed ID: 7537849
[TBL] [Abstract][Full Text] [Related]
4. Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner.
Farooq A; Plotnikova O; Zeng L; Zhou MM
J Biol Chem; 1999 Mar; 274(10):6114-21. PubMed ID: 10037694
[TBL] [Abstract][Full Text] [Related]
5. A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis.
Wang HY; Zamorano J; Keegan AD
J Biol Chem; 1998 Apr; 273(16):9898-905. PubMed ID: 9545332
[TBL] [Abstract][Full Text] [Related]
6. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities.
Wolf G; Trüb T; Ottinger E; Groninga L; Lynch A; White MF; Miyazaki M; Lee J; Shoelson SE
J Biol Chem; 1995 Nov; 270(46):27407-10. PubMed ID: 7499194
[TBL] [Abstract][Full Text] [Related]
7. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
[TBL] [Abstract][Full Text] [Related]
8. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
[TBL] [Abstract][Full Text] [Related]
9. Identification of a NPXY motif in growth factor receptor-bound protein 14 (Grb14) and its interaction with the phosphotyrosine-binding (PTB) domain of IRS-1.
Rajala RV; Chan MD
Biochemistry; 2005 Jun; 44(22):7929-35. PubMed ID: 15924411
[TBL] [Abstract][Full Text] [Related]
10. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
Ward CW; Gough KH; Rashke M; Wan SS; Tribbick G; Wang J
J Biol Chem; 1996 Mar; 271(10):5603-9. PubMed ID: 8621421
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a direct interaction between insulin receptor substrate-1 and Shc.
Kasus-Jacobi A; Perdereau D; Tartare-Deckert S; Van Obberghen E; Girard J; Burnol AF
J Biol Chem; 1997 Jul; 272(27):17166-70. PubMed ID: 9202037
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.
Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ
Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566
[TBL] [Abstract][Full Text] [Related]
13. Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains.
He W; O'Neill TJ; Gustafson TA
J Biol Chem; 1995 Oct; 270(40):23258-62. PubMed ID: 7559478
[TBL] [Abstract][Full Text] [Related]
14. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
15. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
[TBL] [Abstract][Full Text] [Related]
16. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein.
Borg JP; Ooi J; Levy E; Margolis B
Mol Cell Biol; 1996 Nov; 16(11):6229-41. PubMed ID: 8887653
[TBL] [Abstract][Full Text] [Related]
17. The PI/PTB domain: a new protein interaction domain involved in growth factor receptor signaling.
Margolis B
J Lab Clin Med; 1996 Sep; 128(3):235-41. PubMed ID: 8783629
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
19. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
[TBL] [Abstract][Full Text] [Related]
20. In vitro binding and phosphorylation of insulin receptor substrate 1 by the insulin receptor. Role of interactions mediated by the phosphotyrosine-binding domain and the pleckstrin-homology domain.
Backer JM; Wjasow C; Zhang Y
Eur J Biochem; 1997 Apr; 245(1):91-6. PubMed ID: 9128728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
